Chronic low-level mercury exposure, BDNF polymorphism, and associations with self-reported symptoms and mood

Toxicological Sciences

Volumn 81, Issue 2, 2004, Pages 354-363

  Heyer, Nicholas J ^a   Echeverria, Diana ^a,b   Bittner Jr , Alvah C ^a,b   Farin, Federico M ^b   Garabedian, Claire C ^a   Woods, James S ^a,b  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

BDNF; Brain derived neurotrophic factor; Mercury; Mood; Neurobehavioral; Polymorphism; Symptoms

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MERCURY; METHIONINE; VALINE;

ADULT; AGE; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; AUTOMATION; CALCULATION; CHEEK; CIGARETTE SMOKING; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION FUNCTION; DENTAL ASSISTANT; DENTIST; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MULTIPLE REGRESSION; OCCUPATIONAL EXPOSURE; QUESTIONNAIRE; RACE; SAMPLING; SCORING SYSTEM; SELF REPORT; SOCIAL STATUS; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; URINALYSIS;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CROSS-SECTIONAL STUDIES; DENTAL ASSISTANTS; DENTISTS; FEMALE; GENOTYPE; HUMANS; MALE; MERCURY; MERCURY POISONING; MERCURY POISONING, NERVOUS SYSTEM; MIDDLE AGED; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC; QUESTIONNAIRES; SEX CHARACTERISTICS; WASHINGTON;

NICOTIANA TABACUM;

EID: 5744253114     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh220     Document Type: Article

References (39)

1. Albers, J. W., Kallenbach, L. R., Fine, L. J., Langolf, G. D., Wolfe, R. A., Donofrio, P. D., Alessi, A. G., Stolp-Smith, K. A., Bromberg, M. B., and the Mercury Workers Study Group. (1988). Neurological abnormalities associated with remote occupational elemental mercury exposure. Ann. Neurol. 24, 651-659.
2. Anger, W. K., Liang, Y. X., Nell, V., Kang, S. K., Cole, D., Bazylewicz-Walczak, B., Rohlman, D. S., and Sizemore, O. J. (2000). Lessons learned - 15 years of the WHO-NCTB: a review. Neurotoxicol. 21, 837-846.
3. Bittner, A., Echeverria, D., Woods, J., Heyer, N., Martin, M. and Mahurin, R. (1998) Behavioral Effects of Low Level Exposure to Mercury Hg Among Dental Professionals.: A cross-study evaluation of psychomotor effects Neurotoxicol. Teratol. 20, 429-439.
4. Burkhalter, J., Fiumelli, H., Allaman, I., Chatton, J. Y., and Martin, J. L. (2003). Brain-derived neurotropic factor stimulates energy metabolism in developing cortical neurons. J. Neurosci. 23, 8212-8220.
5. Carter, N., Iregren, A., Soderman, E., Olson, B. A., Karlson, B., Lindelof, B., Lundberg, I., and Osterberg, K. (2002). Euroquest-a questionnaire for solvent related symptoms: factor structure, item analysis and predictive validity. Neurotoxicology 23, 711-717.
6. Chouaniere, D., Cassitto, M. G., Spurgeon, A., Verdict, A., and Gilioli, R. (1997). An international questionnaire to explore neurotoxic symptoms. Env. Res. 73, 70-72.
7. Clarkson, T. W. (1989). Mercury. J. Am. Coll. Toxicol. 8, 1291-1296.
8. Clarkson, T. W., Magos, L., and Myers, G. J. (2003). The toxicology of mercury - Current exposures and clinical manifestations. N. Engl. J. Med. 349, 1731-1737.
9. Echeverria, D., Heyer, N. J., Bittner A.C. Jr., Rohlman, D., and Woods, J. (2002). Test-retest reliability and factor stability of the Behavioral Evaluation for Epidemiology Studies test battery. Perceptual Motor Skills 95, 845-867.
10. Echeverria, D., Aposhian, V., Woods, J., Heyer, N., Aposhian, M. M., Bittner, A. C., and Mahurin, R. K. (1998). Neurobehavioral effects from exposure to dental amalgam Hg: New distinctions between recent exposure and Hg body burden. FASEB J. 12, 971-980.
11. Echeverria, D., Heyer, N. J., Martin, M. D., Naleway, C. A., Woods, J. S., and Bittner, A. C. (1995a). Behavioral effects of low-level exposure to Hg° among dentists. Neurotoxicol. Teratol. 17, 161-168.
12. Echeverria, D., White R., Sampaio, C. (1995b). A Neurobehavioral Evaluation of PCE Exposure: I. A Possible Relationship Between Clinical and Pre-clinical Effects. J. Occup. Med. 37, 667-680.
13. Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M. et al. (2003). The BDNF va166met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269.
14. Factor-Litvak, P., Hasselgren, G., Jacobs, D., Begg, M., Kline, J., Geier, J. Mervish, N., Schoenholtz, S. and Graziano, J. (2003). Mercury derived from dental amalgams and neuropsychologic function. Environ. Health Perspect. 111, 719-723.
15. Hall, D., Dhilla, A., Charalambous, A., Gogos, J. A., and Karayiorgou, M. (2003). Sequence variants of the brain-derived neutropic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am. J. Hum. Genet. 73, 370-376.
16. Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., and Weinberger, D. R. (2003). Brain-derived neurotrophic factor va166metpolymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23, 6690-6694.
17. Heyer, N. J., Bittner, A. C., Echeverria, D., et al. (1996). Analyzing multivariate neurobehavioral outcomes in occupational studies: A comparison of approaches. Neurotoxicol. Teratol. 18, 401-406.
18. Ihrig, A, Triebig, G., and Dietz, M. C. (2001). Evaluation of a modified German version of the Q16 questionnaire for neurotoxic symptoms in workers exposed to solvents. Occup. Environ. Med. 58, 19-23.
19. Karlson, B, Osterberg, K., and Orbaek, P. (2000). Euroquest: The validity of a new symptom questionnaire. Neurotoxicology 21, 783-90.
20. Kingman, A., Albertini, T., Brown, L. J. (1998). Mercury concentrations in urine and whole blood associated with amalgam exposure in a US military population. J. Dent. Res. 77, 461-471.
21. Langworth, S., Almkvist, O., Soderman, E., and Wikstrom, B. O. (1992). Effects of occupational exposure to mercury vapour on the central nervous system. Br. J. Ind. Med. 49, 545-555.
22. Langworth, S., Sallsten, G., Barregard, L., Cynkier, I., Lind, M. L., and Soderman, E. (1997). Exposure to mercury vapor and impact on health in the dental profession in Sweden. J. Dent. Res. 76, 1397-1404.
23. Luderer, U., Tornero-Velez, R., Shay, T., Rappaport, S., Heyer, N., Echeverria, D. (2004). Temporal association between serum prolactin concentration and exposure to styrene. Occup. Environ. Med. 61, 325-33.
24. Lundberg, I., Hogberg, M., Michelsen, H., Nise, G., and Hogstedt, C. (1997). Evaluation of the Q16 questionnaire on neurotoxic symptoms and a review of its use. Occup. Environ. Med. 54, 343-350.
25. Marx, J. (2003). Minor variation in growth-factor gene impairs human memory. Science 299, 639-640.
26. McNair, D. M., Lorr, M., and Droppleman, L. F. (1971). EITS Manual - Profile of Mood States. Educational and Industrial Testing Service. San Diego, CA.
27. Naleway, C., Sakaguchi, R., Mitchell, E., Muller, T., Ayer, W. A., and Hefferren, J. J. (1985). Urinary mercury levels in US dentists, 1975-1983: Review of Health Assessment Program. J. Am. Dent. Assoc. 111, 37-42.
28. Ngim, C. H., Foo, S. C., Boey, K. W., and Jeyaratnam, J. (1992). Chronic neurobehavioral effects of elemental mercury in dentists. Br. J. Ind. Med. 49, 782-790.
29. Piikivi, L., and Hänninen, H. (1989). Subjective symptoms and psychological performance of chlor-alkali workers. Scand. J. Work Environ. Health. 15, 69-74.
30. Piikivi, L., Hänninen, H., Martelin, T., and Mantere, P. (1984). Psychological performance and long-term exposure to mercury vapors. Scand. J. Work. Environ. Health. 10, 35-41.
31. Pingree, S. D., Simmonds, P. L. and Woods, J. S. (2001). Effects of 2,3-dimer-capto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats. Toxicol. Sci. 61, 224-233.
32. Pranjic, N., Sinanovic, O., and Jakubovic, R. (2003). Chronic psychological effects of exposure to mercury vapour among chlorine-alkali plant workers. Med. Lav. 94, 531-541.
33. Ribases, M., Gratacos, M., Armengol, L., de Cid, R., Badia, A., Jimenez, L., Solano, R., Vallejo, J., Fernandez, F., and Estivill, X. (2003). Met66 in the brain-derived neurotropic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol. Psych. 8, 745-751.
34. Ritchie, K. A., Gilmour, W. H., Macdonald, E. B., Burke, F. J., McGowan, D. A., Dale, I. M., Hammersley, R., Hamilton, R. M., Binnie, V., and Collington, D. (2002). Health and neuropsychological functioning of dentists exposed to mercury. Occup. Environ. Med. 59, 287-293.
35. Shapiro, I.M., Cornblath, D.R., Sumner, A.J., Uzzell, B., Spitz, L.K., Ship, I.I. and Bloch, P. (1982). Neurophysiological and neuropsychological function in mercury-exposed dentists. Lancet 1(8282), 1147-1150.
36. Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S. et al. (2003). Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry 54, 70-75.
37. Smargiassi, A., Bergamaschi E., Mutti A. and Cella M. T. (1998). Predictive validity of the Q16 questionnaire: A comparison between reported symptoms and neurobehavioral tests. Neurotoxicol. 19, 703-8.
38. Soleo, L., Urbano, M. L., Petrera, V., and Ambrosi, L. (1990). Effects of low exposure to inorganic mercury on psychological performance. Br. J. Ind. Med. 47, 105-109.
39. World Health Organization (1986). Annex 3: Subjective Symptoms Questionaire. In World Health Organization (WHO) - Recommended, Neurobehavioral Core Test Battery (NCTB), Operational Guide, pp. 70-72. World Health Organization, Office of Occupational Health, Geneva. Available only on the WHO website: http://whqlibdoc.who.int/hq/1985-86/a78520.pdf.